I‐Mei Siu

6.8k total citations
22 papers, 823 citations indexed

About

I‐Mei Siu is a scholar working on Molecular Biology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, I‐Mei Siu has authored 22 papers receiving a total of 823 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Genetics and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in I‐Mei Siu's work include Glioma Diagnosis and Treatment (8 papers), Cancer Cells and Metastasis (4 papers) and Sarcoma Diagnosis and Treatment (4 papers). I‐Mei Siu is often cited by papers focused on Glioma Diagnosis and Treatment (8 papers), Cancer Cells and Metastasis (4 papers) and Sarcoma Diagnosis and Treatment (4 papers). I‐Mei Siu collaborates with scholars based in United States, United Kingdom and Italy. I‐Mei Siu's co-authors include Gregory J. Riggins, Gary L. Gallia, Jennifer B. Edwards, Betty Tyler, Avadhut D. Joshi, Charles G. Eberhart, Shailaja Kishan Rao, Christine L. Hann, Anita Lal and Robert L. Strausberg and has published in prestigious journals such as PLoS ONE, Oncogene and Genome Research.

In The Last Decade

I‐Mei Siu

22 papers receiving 810 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
I‐Mei Siu United States	16	494	292	190	160	121	22	823
Anke Waha Germany	19	967 2.0×	215 0.7×	213 1.1×	166 1.0×	85 0.7×	29	1.2k
Koji Oka Japan	9	310 0.6×	351 1.2×	195 1.0×	227 1.4×	138 1.1×	23	727
Lara Perryman United Kingdom	13	516 1.0×	327 1.1×	204 1.1×	170 1.1×	89 0.7×	19	850
Vinay Sagar United States	19	712 1.4×	190 0.7×	231 1.2×	361 2.3×	214 1.8×	46	1.3k
Angela A.G. van Tilborg Netherlands	15	690 1.4×	134 0.5×	201 1.1×	305 1.9×	135 1.1×	23	1.1k
Michael Badruddoja United States	8	238 0.5×	387 1.3×	160 0.8×	167 1.0×	152 1.3×	20	681
Jana Karásková Canada	17	870 1.8×	248 0.8×	333 1.8×	379 2.4×	108 0.9×	22	1.4k
John J. Halliday United States	7	309 0.6×	303 1.0×	212 1.1×	231 1.4×	57 0.5×	9	731
Tina Zheng United States	4	305 0.6×	205 0.7×	159 0.8×	158 1.0×	75 0.6×	7	626
Alexandra Borodovsky United States	14	698 1.4×	312 1.1×	229 1.2×	220 1.4×	79 0.7×	26	1.0k

Countries citing papers authored by I‐Mei Siu

Since Specialization

Citations

This map shows the geographic impact of I‐Mei Siu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I‐Mei Siu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I‐Mei Siu more than expected).

Fields of papers citing papers by I‐Mei Siu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I‐Mei Siu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I‐Mei Siu. The network helps show where I‐Mei Siu may publish in the future.

Co-authorship network of co-authors of I‐Mei Siu

This figure shows the co-authorship network connecting the top 25 collaborators of I‐Mei Siu. A scholar is included among the top collaborators of I‐Mei Siu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I‐Mei Siu. I‐Mei Siu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhao, Tianna, I‐Mei Siu, Haoyu Zhang, et al.. (2021). AZD8055 enhances in vivo efficacy of afatinib in chordomas. The Journal of Pathology. 255(1). 72–83. 11 indexed citations

Zhao, Tianna, I‐Mei Siu, Haoyu Zhang, et al.. (2019). RARE-29. AZD8055 ENHANCES IN VIVO EFFICACY OF AFATINIB IN CHORDOMAS. Neuro-Oncology. 21(Supplement_6). vi227–vi227. 1 indexed citations

Binder, Zev A., Kelli M. Wilson, Vafi Salmasi, et al.. (2016). Establishment and Biological Characterization of a Panel of Glioblastoma Multiforme (GBM) and GBM Variant Oncosphere Cell Lines. PLoS ONE. 11(3). e0150271–e0150271. 21 indexed citations

Neidert, Marian C., I‐Mei Siu, Vanessa Charubhumi, et al.. (2015). Ferromagnetic Dissection in a Rat Glioma Model. Journal of Cancer Therapy. 6(7). 613–621. 1 indexed citations

Siu, I‐Mei, Jacob Ruzevick, Qi Zhao, et al.. (2013). Erlotinib Inhibits Growth of a Patient-Derived Chordoma Xenograft. PLoS ONE. 8(11). e78895–e78895. 35 indexed citations

Binder, Zev A., I‐Mei Siu, Charles G. Eberhart, et al.. (2013). Podocalyxin-Like Protein Is Expressed in Glioblastoma Multiforme Stem-Like Cells and Is Associated with Poor Outcome. PLoS ONE. 8(10). e75945–e75945. 38 indexed citations

Joshi, Avadhut D., Watcharin Loilome, I‐Mei Siu, et al.. (2012). Evaluation of Tyrosine Kinase Inhibitor Combinations for Glioblastoma Therapy. PLoS ONE. 7(10). e44372–e44372. 37 indexed citations

Yoshimura, Junichi, et al.. (2012). The effects of temozolomide delivered by prolonged intracerebral microinfusion against the rat brainstem GBM allograft model. Child s Nervous System. 28(5). 707–713. 12 indexed citations

Siu, I‐Mei, Vafi Salmasi, Brent A. Orr, et al.. (2012). Establishment and characterization of a primary human chordoma xenograft model. Journal of neurosurgery. 116(4). 801–809. 24 indexed citations

10.

Tyler, Betty, Sarah Wadsworth, Violette Renard Recinos, et al.. (2011). Local delivery of rapamycin: a toxicity and efficacy study in an experimental malignant glioma model in rats. Neuro-Oncology. 13(7). 700–709. 28 indexed citations

11.

Hsu, Wesley, I‐Mei Siu, Gustavo Pradilla, et al.. (2011). Animal model of intramedullary spinal cord glioma using human glioblastoma multiforme neurospheres. Journal of Neurosurgery Spine. 16(3). 315–319. 12 indexed citations

12.

Bai, Ren-Yuan, I‐Mei Siu, Betty Tyler, et al.. (2010). Evaluation of retinoic acid therapy for OTX2-positive medulloblastomas. Neuro-Oncology. 12(7). 655–663. 23 indexed citations

13.

Rao, Shailaja Kishan, Jennifer B. Edwards, Avadhut D. Joshi, I‐Mei Siu, & Gregory J. Riggins. (2009). A survey of glioblastoma genomic amplifications and deletions. Journal of Neuro-Oncology. 96(2). 169–179. 104 indexed citations

14.

Siu, I‐Mei, Ren-Yuan Bai, Gary L. Gallia, et al.. (2008). Coexpression of neuronatin splice forms promotes medulloblastoma growth. Neuro-Oncology. 10(5). 716–724. 25 indexed citations

15.

Beaty, Robert M., Jennifer B. Edwards, Kathy Boon, et al.. (2006). PLXDC1 (TEM7) is identified in a genome-wide expression screen of glioblastoma endothelium. Journal of Neuro-Oncology. 81(3). 241–248. 34 indexed citations

16.

Gallia, Gary L., Vikki Rand, I‐Mei Siu, et al.. (2006). PIK3CA Gene Mutations in Pediatric and Adult Glioblastoma Multiforme. Molecular Cancer Research. 4(10). 709–714. 123 indexed citations

17.

Boon, Kathy, Jennifer B. Edwards, I‐Mei Siu, et al.. (2003). Comparison of medulloblastoma and normal neural transcriptomes identifies a restricted set of activated genes. Oncogene. 22(48). 7687–7694. 63 indexed citations

18.

Siu, I‐Mei, Anita Lal, Jill R. Blankenship, Naji Aldosari, & Gregory J. Riggins. (2003). c-Myc promoter activation in medulloblastoma.. PubMed. 63(16). 4773–6. 28 indexed citations

19.

Siu, I‐Mei, Anita Lal, & Gregory J. Riggins. (2001). A database for regional gene expression in the human brain. Gene Expression Patterns. 1(1). 33–38. 11 indexed citations

20.

Loging, William, Anita Lal, I‐Mei Siu, et al.. (2000). Identifying Potential Tumor Markers and Antigens by Database Mining and Rapid Expression Screening. Genome Research. 10(9). 1393–1402. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact